$RARX Ra Pharmaceuticals, Inc. Insider Trading
Get free email notifications about insider trading in Ra Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Ra Pharmaceuticals, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Ra Pharmaceuticals, Inc. for free.
CIK Number: 0001481512
IRS Number: 262908274
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: RARX
Company Address: 87 CAMBRIDGE PARK DRIVE CAMBRIDGE 02140
Phone number: (617) 401-4060
Market Capitalization: $405.38M
Prev close: $18.17
Average Daily Volume: 73,861
Days Low: $17.37
Year Low: $12.05
Year High: $18.44
Ra Pharmaceuticals, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | NEW ENTERPRISE ASSOCIATES 13 L ... | 10% Owner | Sell | D | 0.00 | 6,135,234 | 0 | 0 | 6.1 M to 0 (-100.00 %) |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 19.88 | 15,000 | 298,200 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 9.90 | 15,000 | 148,500 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Mathers Edward T | Director | Option Exercise | D | 22.37 | 15,000 | 335,550 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 0.00 | 20,833 | 0 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 21.00 | 311,000 | 6,531,000 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 7.33 | 125,000 | 916,250 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 16.64 | 225,000 | 3,744,000 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 5.60 | 164,285 | 919,996 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 241,460 | 692,990 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Option Exercise | D | 2.87 | 139,371 | 399,995 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Treco Douglas A | President and CEO | Sell | D | 48.00 | 234,707 | 11,265,936 | 0 | 234.7 K to 0 (-100.00 %) |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 0.00 | 10,416 | 0 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 21.00 | 133,000 | 2,793,000 | 0 | |
Apr 03 2020 | RARX | Ra Pharmaceuticals ... | Lubner David Charles | Executive VP and CF ... | Option Exercise | D | 7.33 | 62,500 | 458,125 | 0 |